We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTCF
2551
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$289K ﹤0.01%
22,937
+6,924
+43% +$87.6K
CHRD icon
2552
Chord Energy
CHRD
$7.33B
$288K ﹤0.01%
+1,969
New +$272K
INGN icon
2553
Inogen
INGN
$156M
$288K ﹤0.01%
8,869
+727
+9% +$22.9K
SXI icon
2554
Standex International
SXI
$4.03B
$287K ﹤0.01%
2,872
+658
+30% +$68.9K
VRA icon
2555
Vera Bradley
VRA
$94.7M
$286K ﹤0.01%
37,341
+6,900
+23% +$54.6K
PSTH
2556
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$286K ﹤0.01%
14,391
ORC
2557
Orchid Island Capital
ORC
$1.33B
$284K ﹤0.01%
17,447
+587
+3% +$11.1K
GDRX icon
2558
GoodRx Holdings
GDRX
$1.23B
$282K ﹤0.01%
14,600
+5,300
+57% +$122K
CTO
2559
CTO Realty Growth
CTO
$824M
$281K ﹤0.01%
12,708
+291
+2% +$6K
PRAX icon
2560
Praxis Precision Medicines
PRAX
$10.5B
$281K ﹤0.01%
1,835
+53
+3% +$10.9K
CELL
2561
DELISTED
PhenomeX Inc. Common Stock
CELL
$280K ﹤0.01%
39,349
-433,811
-92% -$3.59M
AGTC
2562
DELISTED
Applied Genetic Technologies Corporation
AGTC
$280K ﹤0.01%
262,055
RMO
2563
DELISTED
Romeo Power, Inc.
RMO
$280K ﹤0.01%
187,922
+44,583
+31% +$93.8K
CLOV icon
2564
Clover Health Investments
CLOV
$2.38B
$279K ﹤0.01%
78,495
+32,178
+69% +$93.3K
EGLE
2565
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$279K ﹤0.01%
+4,094
New +$217K
NRC icon
2566
NRC Health Common Stock
NRC
$459M
$278K ﹤0.01%
7,007
+282
+4% +$11K
XXII
2567
22nd Century Group
XXII
$1.37M
0
NPKI
2568
NPK International
NPKI
$1.19B
$275K ﹤0.01%
75,120
-4,700
-6% -$17.5K
CRDO icon
2569
Credo Technology Group
CRDO
$51B
$273K ﹤0.01%
+17,943
New +$261K
SEB icon
2570
Seaboard Corp
SEB
$4.03B
$273K ﹤0.01%
65
-6
-8% -$23.2K
APVO icon
2571
Aptevo Therapeutics
APVO
$5.25M
0
FOR icon
2572
Forestar Group
FOR
$1.49B
$271K ﹤0.01%
+15,234
New +$285K
ONIT
2573
Onity Group
ONIT
$325M
$271K ﹤0.01%
11,424
+200
+2% +$6.53K
EGY icon
2574
Vaalco Energy
EGY
$596M
$270K ﹤0.01%
41,300
-4,700
-10% -$24.6K
KALV
2575
DELISTED
KalVista Pharmaceuticals
KALV
$270K ﹤0.01%
18,327
+3,666
+25% +$52.7K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.